Abstract:Background/Purpose: We have previously shown that pre‐exposure to IL‐1β augments the immunosuppressive activity of MSC using the mixed lymphocyte reaction as a readout assay. In this project, we studied the profiles of inflammatory cytokines secreted by MSCs at the protein level to identify biomarkers in in vitro primed MSCs. The objective of this study was to determine the MSC response to “danger signals.” Methods: MSCs were isolated from a healthy donor and cultured as per a protocol published earlier by the Skeletal Research Center. After three passages, 200,000 cells per 35 mm culture dish were incubated in 2 ml DMEM with 10% fetal bovine serum at 37°C for 5 days until 90% confluent. The MSCs were then treated with LPS (10 μg/ml), IL‐1β (25 ng/ml), TNF‐α (50 ng/ml), or poly (I:C) (30 ng/ml) overnight (18 hours). Control and treatment groups were done in triplicate. The culture media were then collected and analyzed for secreted mediators using the RayBiotech® Human Cytokine Array (2000), as per the manufacturer's protocol. Chemiluminescense was detected using Kodak BioMax MR film, and was analyzed using the ImageJ program ( rsbweb.nih.gov ). Normalization and fold‐difference computations were then performed in MS Excel. Pathway analysis for biomarker detection was performed using the Ingenuity ( ingenuity.com ) program by the CWRU proteomics center. Results: There were clear distinctions in the patterns of inflammatory mediators produced by MSC upon exposure to LPS versus poly (I:C). LPS stimulated the production of mediators that affect mostly neutrophil chemotaxis and activation, including IL‐8 (1.8 fold), CXCL7 (2 fold), CXCL5 (2.4 fold), CXCL1 (1.6 fold). However, poly (I:C) induced mediators with activities on T cells and NK cells including IL‐15 (18 fold), IL‐4 (23 fold), TGF‐β3 (9.7 fold), CCL‐18 (4.6 fold). While poly (I:C) stimulated IL‐1β production (2.6 fold), LPS did not (0.7 fold), and neither agent increased TNF‐α significantly (1.3 and 2.1 fold). Interestingly, there was marked production of CCL1 (12 fold) upon exposure of MSC to IL‐1β but not to LPS (0.6 fold), TNF‐α (1.3) or poly (I:C) (2.1 fold). Conclusion: Priming MSC by TLRs ligands triggered different cytokine and chemokine expression profiles. These profile patterns may signify framework of the upcoming immune responses in the tissue. Accordingly, the candidate biomarkers for ongoing MSC immunomodulatory activities should include those for neutrophils versus those for T/NK cells. Furthermore, our results strongly suggest involvement of IL‐1β in MSCmediated activation of T‐regulatory cells by induction of the CCR‐8 ligand, CCL‐1. CCR‐8 is a known biomarker identifying CD4 + memory T‐cells enriched for FoxP3 + T‐regulatory cells and is involved in delivery of immunosuppression.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the secretion of immunomodulatory factors in mesenchymal stem cells (MSCs) after in vitro exposure to "danger signals" (such as LPS, IL - 1β, TNF - α, poly (I:C), etc.). Specifically, the researchers hope to identify molecules that can be used as biomarkers by analyzing the cytokine secretion patterns of MSCs under these stimuli, so as to better understand how MSCs respond to different immune stimuli and possibly predict the framework of their immune responses in tissues. ### Research Background and Purpose Researchers have previously demonstrated that pre - exposure to IL - 1β can enhance the immunosuppressive activity of MSCs. On this basis, this project aims to determine the response patterns of MSCs to "danger signals" by detecting the protein levels of inflammatory cytokines secreted by MSCs after in vitro pretreatment. ### Methods - **Cell Culture**: MSCs were isolated from healthy donors and cultured according to the protocol previously published by the Case Western Reserve University Skeletal Research Center. - **Stimulation Treatment**: When the cells reached 90% confluence, they were treated with LPS (10 ng/ml), IL - 1β (25 ng/ml), TNF - α (50 ng/ml) or poly (I:C) (30 ng/ml) for 18 hours respectively. - **Analysis Method**: The culture medium was collected, and the secreted mediators were detected using RayBiotech® Human Cytokine Array (2000). Chemiluminescence was detected by Kodak BioMax MR film and analyzed using the ImageJ program. Data were normalized and fold - difference calculations were performed in MS Excel. Pathway analysis was performed using the Ingenuity program to detect biomarkers. ### Results - **Responses under Different Stimuli**: - LPS mainly stimulated the production of mediators affecting neutrophil chemotaxis and activation, such as IL - 8 (1.8 - fold), CXCL7 (2 - fold), CXCL5 (2.4 - fold), CXCL1 (1.6 - fold). - poly (I:C) induced mediators acting on T cells and NK cells, including IL - 15 (18 - fold), IL - 4 (23 - fold), TGF - β (9.7 - fold), CCL - 18 (4.6 - fold). - poly (I:C) also stimulated the production of IL - 1β (2.6 - fold), while LPS had no significant effect (0.7 - fold). Neither of the two stimuli significantly increased the expression of TNF - α (1.3 - fold and 2.1 - fold respectively). - In particular, under IL - 1β stimulation, MSCs significantly produced CCL1 (12 - fold), while it was not obvious under LPS (0.6 - fold), TNF - α (1.3 - fold) or poly (I:C) (2.1 - fold) stimulation. ### Conclusion Pretreatment with TLRs ligands triggers different cytokine and chemokine expression profiles. These profiles may represent the framework of the upcoming immune response in tissues. Therefore, as candidate biomarkers for MSC immunomodulatory activities, those markers for neutrophils as well as those for T/NK cells should be included. In addition, the research results strongly suggest that IL - 1β plays an important role in activating Treg cells by inducing CCR - 8 ligand CCL - 1. CCR - 8 is a known biomarker for identifying CD4+ memory T cells rich in FoxP3+ Treg cells and is involved in transmitting immunosuppressive effects.

A125: Immunomodulatory Factors Produced by Mesenchymal Stem Cells After in vitro Priming with Danger Signals

Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors

Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro

Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation

The effect of TLR3 priming conditions on MSC immunosuppressive properties

Priming With Toll-Like Receptor 3 Agonist Poly(I:C) Enhances Content of Innate Immune Defense Proteins but Not MicroRNAs in Human Mesenchymal Stem Cell-Derived Extracellular Vesicles

The TLR7 Agonist Imiquimod Promote the Immunogenicity of Msenchymal Stem Cells

Poster Corner 6: Sepsis and Cardiovascular Dynamics 075-MESENCHYMAL STEM CELLS ALTERED T LYMPHOCYTE DIFFERENTIATION UPON LPS OR HYPOXIA CHALLENGE VIA PARACRINE TRANSFORMING GROWTH FACTOR BETA-1 IN VITRO

The Interaction Between Mesenchymal Stem Cells and the Immune System

The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming

Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model

MCP-1 Priming Enhanced the Therapeutic Effects of Human Mesenchymal Stromal Cells on Contact Hypersensitivity Mice by Activating the COX2-PGE2/STAT3 Pathway.

Immunosupressive Property of Mesenchymal Stem Cells (mscs) in Mixed Lymphocyte Reactions in Vitro.

Single-cell transcriptome analysis reveals the effectiveness of cytokine priming irrespective of heterogeneity in mesenchymal stromal cells

Mesenchymal stem cells modulate IL-17 and IL-9 production induced by Th17-inducing cytokine conditions in autoimmune arthritis: an explorative analysis

Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation

Preconditioning with interleukin‐1 beta and interferon‐gamma enhances the efficacy of human umbilical cord blood‐derived mesenchymal stem cells‐based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3‐dioxygenase activity in dextran sulfate sodium‐induced colitis

In vitro MSC function is related to clinical reaction in vivo

Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles

Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell

Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression